Cargando…
Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956484/ https://www.ncbi.nlm.nih.gov/pubmed/31931847 http://dx.doi.org/10.1186/s13046-019-1518-z |
| _version_ | 1783487160651874304 |
|---|---|
| author | Lai, Ssu-Chuan Su, Yu-Ting Chi, Ching-Chi Kuo, Yung-Che Lee, Kam-Fai Wu, Yu-Chih Lan, Pei-Chi Yang, Muh-Hwa Chang, Te-Sheng Huang, Yen-Hua |
| author_facet | Lai, Ssu-Chuan Su, Yu-Ting Chi, Ching-Chi Kuo, Yung-Che Lee, Kam-Fai Wu, Yu-Chih Lan, Pei-Chi Yang, Muh-Hwa Chang, Te-Sheng Huang, Yen-Hua |
| author_sort | Lai, Ssu-Chuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6956484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69564842020-01-17 Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation Lai, Ssu-Chuan Su, Yu-Ting Chi, Ching-Chi Kuo, Yung-Che Lee, Kam-Fai Wu, Yu-Chih Lan, Pei-Chi Yang, Muh-Hwa Chang, Te-Sheng Huang, Yen-Hua J Exp Clin Cancer Res Correction BioMed Central 2020-01-13 /pmc/articles/PMC6956484/ /pubmed/31931847 http://dx.doi.org/10.1186/s13046-019-1518-z Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Lai, Ssu-Chuan Su, Yu-Ting Chi, Ching-Chi Kuo, Yung-Che Lee, Kam-Fai Wu, Yu-Chih Lan, Pei-Chi Yang, Muh-Hwa Chang, Te-Sheng Huang, Yen-Hua Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title | Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title_full | Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title_fullStr | Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title_full_unstemmed | Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title_short | Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation |
| title_sort | correction to: dnmt3b/oct4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through il-6/stat3 regulation |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956484/ https://www.ncbi.nlm.nih.gov/pubmed/31931847 http://dx.doi.org/10.1186/s13046-019-1518-z |
| work_keys_str_mv | AT laissuchuan correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT suyuting correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT chichingchi correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT kuoyungche correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT leekamfai correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT wuyuchih correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT lanpeichi correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT yangmuhhwa correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT changtesheng correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation AT huangyenhua correctiontodnmt3boct4expressionconferssorafenibresistanceandpoorprognosisofhepatocellularcarcinomathroughil6stat3regulation |